Dr. Han Ying
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Han Ying
Dr. Han Ying is recorded as CEO at Gyre Therapeutics, Inc. (GYRE). Gyre Therapeutics, Inc. reported in an 8-K filed December 15, 2023 that Dr. Han Ying was appointed Chief Executive Officer, effective January 15, 2024.
“On December 13, 2023, Gyre Therapeutics, Inc. (the "Company") appointed Dr. Han Ying as the Company's Chief Executive Officer, effective January 15, 2024, to succeed Dr. Charles Wu, whose employment with the Company will terminate on such date pursuant to his retirement for health reasons.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-01-15–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Gyre Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Charles Wu CEO, Board Member
- Dr. Ying Luo CEO, Board Member
- Ping Zhang CEO, Board Member
- Ying Luo CEO, Board Member
- Ying Luo, Ph.D. CEO, Board Member
- Augustine Lawlor Chairman, Board Member
- Songjiang Ma Chairman, Board Member
- Clinton Musil CFO
- Fletcher Payne CFO
- Ruoyu Chen CFO
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.